The Lone Analyst Who Said Sell Valeant When Hedge Funds Piled InBy
Khmelnitsky watched shares double in a year, before crashing
`I stayed with the call,' Veritas analyst says in interview
In July 2014, Dimitry Khmelnitsky advised investors to sell Valeant Pharmaceuticals International Inc. and then watched the stock double in a year.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.